| Literature DB >> 19402975 |
Alexander Rodriguez-Palacios1, Richard J Reid-Smith, Henry R Staempfli, Danielle Daignault, Nicol Janecko, Brent P Avery, Hayley Martin, Angela D Thomspon, L Clifford McDonald, Brandi Limbago, J Scott Weese.
Abstract
We previously reported Clostridium difficile in 20% of retail meat in Canada, which raised concerns about potential foodborne transmissibility. Here, we studied the genetic diversity of C. difficile in retail meats, using a broad Canadian sampling infrastructure and 3 culture methods. We found 6.1% prevalence and indications of possible seasonality (highest prevalence in winter).Entities:
Mesh:
Substances:
Year: 2009 PMID: 19402975 PMCID: PMC2687045 DOI: 10.3201/eid1505.081084
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Proportion of retail meat packages yielding Clostridium difficile in 4 culture replicates and estimated method sensitivity, Canada, 2006*†
| Sample | Culture method | % Samples with | Culture sensitivity, %‡ | ||||
|---|---|---|---|---|---|---|---|
| Enrichment | Agar | Ground beef | Veal from milk-fed calves | Both‡ | |||
| Rinsate | TCDMNB | CDMNA | 2.7 (4/149)§ | 0 (0/65) | 1.9 (4/214) | 31 | |
| Meat¶ | TCDMNB | CDMNA | 2.7 (4/149)§ | 1.5 (1/65) | 2.3 (5/214) | 39 | |
| Meat¶ | TCDMNB | CDMNA | 1.3 (2/149)§ | 1.5 (1/65) | 1.4 (3/214) | 23 | |
| Meat | TCCFB | Blood |
| 1.3% (2/149) | 1.5 (1/65) | 1.4 (3/214) | 23 |
| Total of contaminated packages# | 6.7 (10/149) | 4.6 (3/65) | 6.1 (13/214)‡ | 100 | |||
*Rinsate, sediment; TCDMNB, in-house C. difficile broth (CM0601; Oxoid, Basingstoke, UK) supplemented with cysteine hydrochloride, moxalactam, norfloxacin (CDMN, SR0173E; Oxoid), and 0.1% sodium taurocholate (Sigma-Aldrich, Inc., St. Louis, MO, USA) (); Meat, 2 g; CDMNA, C. difficile agar supplemented with CDMN and 7% laked horse blood (SR0048C; Oxoid); TCCFB, broth supplemented with D-cycloserine and cefoxitin (SR0096E; Oxoid) and 0.1% sodium taurocholate; Blood, 5% defibrinated sheep blood. †Poor test agreement was found among and between cultures (κ –0.28; p>0.9). ‡Culture sensitivity calculation based on parallel interpretation of all 4 cultures (standard comparator) and 6.1% of overall contamination. Duplicate testing sensitivity ranged from 46.2% (6/13) to 61.5% (8/13). §Represents 2 packages that simultaneously tested positive in 2 culture replicates. ¶Protocol previously used to test meat; duplicate run (). #No statistical differences were found between ground beef and veal in any culture replicate (p>0.1).
Figure 1Distribution of retail grocery stores sampled (n = 210) and proportion with contaminated meat. The overall proportion of stores with >1 meat package contaminated with Clostridium difficile was 5.7%. No statistical differences were observed when comparing the proportions of ground beef contamination in Québec, Ontario, and Saskatchewan, Canada (p>0.2). No comparisons for veal chops were made because Québec was the main source of this commodity; veal from milk-fed calves was not available in Saskatchewan, and only 3 stores had this type of veal during sampling in Ontario.
Molecular characteristics of 15 representative Clostridium difficile strains isolated from 13 of 214 retail meat packages tested in Canada, 2006*
| Type† | % (no.) | Toxin genes‡ | Toxinotype | PFGE§ | Product–culture | Month | Province | |
|---|---|---|---|---|---|---|---|---|
| M26 | 23.1 (3) | A–B–, | NA | Nontypeable | Unnamed | VC–C3 | Feb | QC |
| – | GB–C2 | Jan | ON | |||||
| – | GB–C2 | Jun | SK | |||||
| 077¶ | 23.1 (3) | A+B+, | No | 0 | NAP2 | GB–C3 | Jan | QC |
| – | GB–C1 | Jan | ON | |||||
| – | GB–C3 | Jan | QC | |||||
| J¶ | 23.1 (3) | A+B+, | 18 bp | III | NAP1 | GB–C4 | May | ON |
| NAP1a | GB–C4 | Jun | ON | |||||
| – | VC–C4 | Feb | QC | |||||
| 014¶ | 15.4 (2) | A+B+, | No | 0 | NAP4 | GB–C1 | May | QC |
| – | GB–C2 | Jan | QC | |||||
| C | 7.7 (1) | A+B+, | No | – | – | GB–C1 | Jan | ON |
| F | 7.7 (1) | A-B+, | No | VIII | NAP9 | GB–C2 | Jan | QC |
| H | 7.7(1) | A+B+, | No | 0 | Unnamed | GB – C1 | Jun | QC |
| K | 7.7(1) | A+B+, | 18 bp | III | NAP1-r | VC–C2 | Aug | QC |
*PFGE, pulsed-field gel electrophoresis; NA, not amplified because it lacks pathogenicity locus; VC, veal chops; GB, ground beef; C1, rinsate/TCDMNB; C2, meat/TCDMNB; C3, meat/TCDMNB duplicate; C4, meat/TCFFB; QC, Québec; ON, Ontario; SK, Saskatchewan; –, not performed. †Bidet’s PCR ribotyping method (); 077 and 014; representative ribotypes with international nomenclatures assigned by Dr Jon Brazier, University of Wales, Wales, in a previous study (). M26, non-toxigenic Canadian meat ribotype lacking pathogenicity locus (pers. com., M. Rupnik, University of Maribor, Slovenia) (). ‡A, B; tcdA and tcdB genes. cdtB, binding segment of binary toxin; – and + superscripts indicate absence or presence of the gene. tcdC gene: no deletions (≈345 bp); 18 bp, deletion type B/C (). §Nomenclature at the Centers for Disease and Control and Prevention, Atlanta, GA, USA. NAP1, North America PFGE type 1. ¶Meat PCR ribotypes matching concurrent local and international human ribotypes (,). Note that 28 C. difficile isolates initially identified were grouped into 15 strains based on molecular characteristics and source of origin; 2 meat samples simultaneously harbored 2 strains.
Figure 2Pulsed-field gel electrophoresis (PFGE)–SmaI dendogram of Clostridium difficile isolates of meat and human origin in Canada. Representative PCR ribotypes 077, 014, M31, and M26 are of meat origin from 2005 (,). PCR ribotype designations are described in Table 2. Note the genetic similarity (94.1%–100%) and antimicrobial resistance profiles between human and meat isolates, especially PCR ribotypes 014 and J. Also note the genetic similarity (81.8%–100%) between meat isolates from 2005 and 2006 for multidrug-resistant epidemic PCR ribotype 077, clindamycin-variable, PCR ribotype 014, and nontoxigenic PCR ribotype M26. Resistance to all 4 antimicrobial drugs was observed in meat isolates of ribotypes 077 and F, which also yielded the highest level of clindamycin resistance (>256 µL/mL; breakpoint: >6 µL/mL). The breakpoints for moxifloxacin () were also used for levofloxacin and gatifloxacin. R (resistant), S (susceptible), and I (intermediate) represent antimicrobial profiles. CDC, Centers for Disease Control and Prevention; NAP, North America PFGE type; NAP1-r, NAP-related strain; Tox, toxinotyping nomenclature (M. Rupnik, Maribor, Slovenia); U, unnamed.